NCT02176187View on ClinicalTrials.gov

Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

December 31, 2004

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Berodual® Respimat® inhaler

fenoterol hydrobromide 50μg + ipratropium bromide 20μg

DRUG

Berodual® metered dose inhaler

fenoterol hydrobromide 50μg + ipratropium bromide 20μg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY